The nervous system medicine sales in Mexico have experienced fluctuations over the past decade. In 2023, the sales stood at USD 1.01 billion. From 2013 to 2023, there was a significant dip and subsequent recovery in the market, with notable variability in year-on-year growth rates. Over the last two years, sales increased by 9.6% in 2022 but saw a slight decline of 1.08% in 2023. The five-year compound annual growth rate (CAGR) leading up to 2023 was 4.7%.
Looking ahead, the market is forecasted to grow steadily, with a projected CAGR of 1% over the next five years, resulting in a total growth rate of 5.09% by 2028. Key future trends to watch for include advancements in biotechnology, increased focus on personalized medicine, and rising investments in healthcare infrastructure.
